抗肿瘤药/ Cultural corridor
当前位置： 首页 > 九洲产品 > 中间体 > 抗肿瘤药
| 排序 | 产品名称 | CAS号 | 用途 |
|---|---|---|---|
| 901-1 | N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-氨基嘧啶 N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine |
152460-10-1 | Imatinib intermediate |
| 901-2 | 4-((4-甲基哌嗪-1-烷基)甲基)苯甲酰氯 4-((4-methylpiperazin-1-yl)methyl)benzoyl chloride |
148077-69-4 | Imatinib intermediate |
| 902-1 | 4-(3-氯-4-氟苯氨基)-7-甲氧基喹唑啉-6-醇 4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol |
184475-71-6 | Gefitinib intermediate |
| 902-2 | N-(3-氯丙基)吗啉 N-(3-Chloropropyl)morpholine |
7357-67-7 | Gefitinib intermediate |
| 903-1 | 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone |
179688-29-0 | Erlotinib intermediate |
| 903-2 | 4-chloro-6,7-di(2-methoxyethoxy)quinazoline |
183322-18-1 | Erlotinib intermediate |
| 903-4 | 3-氨基苯乙炔 3-Aminophenylacetylene |
54060-30-9 | Erlotinib intermediate |
| 904-1 | 4-(4-氨基苯氧基)-N-甲基-2-吡啶甲酰胺 4-(4-Aminophenoxy)-N-methylpicolinamide |
284462-37-9 | Sorafenib intermediate |
| 904-2 | 5-氨基-2-氯三氟甲苯 5-Amino-2-chlorobenzotrifluoride |
320-98-4 | Sorafenib intermediate |
| 905-1 | 4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
641569-94-0 | Nilotinib intermediate |
| 905-2 | 3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
641571-11-1 | Nilotinib intermediate |
| 906-1 | N-(2-(二乙基氨基)乙基)-5-甲酰基-2,4-二甲基-1H-吡咯-3-甲酰胺 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide |
356068-86-5 | Sunitinib intermediate |
| 906-2 | 5-氟-1,3-二氢吲哚-2-酮 5-Fluoro-1,3-dihydro-indol-2-one |
56341-41-4 | Sunitinib intermediate |
| 907-1 | N-(2-氯-6-甲基苯基)-2-[(6-氯-2-甲基-4-嘧啶基)氨基]-5-噻唑甲酰胺 N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide |
302964-08-5 | Dasatinib intermediate |
| 907-2 | N-羟乙基哌嗪 N-(2-Hydroxyethyl)piperazine |
103-76-4 | Dasatinib intermediate |
| 908-1 | 3-氯-4-(3-氟-苄氧基)-苯胺 3-Chloro-4-(3-fluoro-benzyloxy)-phenylamine |
202197-26-0 | Lapatinib intermediate |
| 908-2 | 5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉]-2-呋喃甲醛 5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde |
231278-84-5 | Lapatinib intermediate |
说明：上述产品仅在无专利保护的区域或在相关专利已到期的国家或区域生产或销售。
总共有 17 篇记录 这是第 1 页
浙公网安备 33100202000816号